Location of Repository

Extended duration of the detectable stage by adding HPV test in cervical cancer screening

By M.E. (M.) Van Den Akker-van Marie, M. (Marjolein) van Ballegooijen, L. (Lawrence) Rozendaal, C.J.L.M. (Chris) Meijer and J.D.F. (Dik) Habbema


The human papillomavirus test (HPV) test could improve the (cost-) effectiveness of cervical screening by selecting women with a very low risk for cervical cancer during a long period. An analysis of a longitudinal study suggests that women with a negative Pap smear and a negative HPV test have a strongly reduced risk of developing cervical abnormalities in the years following the test, and that HPV testing lengthens the detectable stage by 2-5 years, compared to Pap smear detection alone

Topics: Cervical cancer screening model, Human papillomavirus
Year: 2003
DOI identifier: 10.1038/sj.bjc.6601355
OAI identifier: oai:repub.eur.nl:66798
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://repub.eur.nl/pub/66798 (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.